The European Patent Office has granted Retarus a Europe-wide patent for the Patient Zero Detection® technology developed by the company.
Patient Zero Detection®: Retarus granted Europe-wide patent
Tags: Patent // Patient Zero Detection
The European Patent Office has granted Retarus a Europe-wide patent for the Patient Zero Detection® technology developed by the company.
Tags: Patent // Patient Zero Detection
When I happened to take a look at our Yammer network this morning, I was reminded once again of what a great company I am actually working for here.
Tags: CSR
A particularly nasty piece of malware is currently doing the rounds – “Emotet”, as the malware has become known, has succeeded in paralyzing entire company networks. Retarus’ ESVE feature allows your email users to see at a glance whether an email has actually been received via an external relay.
Tags: Email Security // ESVE
Dall’ultima release invernale di Salesforce è ora possibile utilizzare anche Retarus Transactional Email per l’invio di e-mail.
Tags: Salesforce // SMTP // Transactional Email
In mid-November we were granted another patent, this time by the European Patent Office (EPO).
Tags: Botnet // Email Security // Patent